Leading Companies - Sterile Injectables Industry

Manufacturers of sterile injectables are expanding their product portfolio through strategies including mergers and acquisitions, which is predicted to drive the growth of the worldwide sterile injectables market over the forecast period. For instance, a contract development and manufacturing organization (CDMO) called Lyophilization Services of New England (LSNE) purchased a manufacturing facility for sterile injectables in León, Spain, in June 2019. Additionally, in February 2014, Nanomi BV (a Dutch injectable business) was purchased by Lupin Limited. A medication for injection is being developed by Nanomi BV, along with about 38 other compounds aimed at the market for branded and generic injectables. Demand for sterile injectables is anticipated to increase as manufacturers invest more to develop their businesses through new manufacturing facilities. Manufacturers of sterile injectables must make significant capital investments in both the production method and the machinery. Due to a scarcity of capital, many pharmaceutical businesses in the United States and Europe are pursuing other corporations for investment.

Coherent Market Insights estimates that the market for Sterile Injectables was valued at US$ 357.4 billion in 2018 and is anticipated to grow at a CAGR of 7.3% from 2019 to 2027.

Major Players in the Sterile Injectables Industry:

1. Pfizer Inc.,

The company was established in 1849, and Manhattan, New York City, is where its corporate headquarters are situated. Through the creation of pharmaceuticals and vaccines, Pfizer seeks to enhance the fields of immunology, cancer, the heart, endocrinology, and neurology. In October 2022, the business successfully acquired Biohaven Pharma's calcitonin gene-related peptide programmes. Pfizer purchased Amplyx Pharmaceuticals in April 2021, which included the rights to the antifungal drug fosmanogepix (APX001).

2. Baxter international Inc.

The company was founded in 1931 and is based in Illinois, United States. The business creates, produces, and sells goods and technologies for treating renal illness, trauma, immunological disorders, infectious diseases, haemophilia, and other acute and chronic medical ailments.  The purchase of Hill-rom by Baxter for $12.4 billion was announced in September 2021.For $12.5 billion, the purchase was finalised in December 2021.

3. Johnson & Johnson Services, Inc., 

The company was established in 1886 and has its main office in New Brunswick, New Jersey. In addition to consumer packaged goods, the company also creates medical devices and drugs. Johnson & Johnson paid $6.5 billion to purchase Momenta Pharmaceuticals in November 2020. Johnson & Johnson declared in November 2022 that it will pay $16.6 billion to buy Abiomed Inc. On December 22, the deal became final.

4. Novartis AG

The business was established in March 1996 and has offices in Basel, Switzerland, and Cambridge, Massachusetts, in the US. All pharmaceutical kinds are covered by Novartis, including prescription, over-the-counter, immunizations, diagnostics, eyeglasses, and veterinary treatment. In addition to managing, advertising, operations, and research, Novartis also engages in a number of direct activities through its companies.

5. Merck & Co., Inc.

The business was founded in 1668, and Rahway, New Jersey is where its headquarters are. Merck produces medicines, vaccines, biologic therapies, and things for animal health. After paying an undisclosed sum for the cattle management company Vence, the company announced in September 2022 that it will merge with Merck Animal Health. In February 2021, Merck Animal Health acquired PrognostiX Poultry.

6. AstraZeneca plc

The company was established in 1999, and its headquarters are in Cambridge, United Kingdom. Its product line includes remedies for conditions related to the heart, respiratory system, inflammatory process, and viruses. In January 2023, AstraZeneca announced that it would purchase CinCor Pharma for $1.8 billion. The business declared in July 2022 that it would add TeneoTwo, which might cost up to $1.3 billion, to its line of blood cancer medications.

7. Gilead Sciences, Inc.

The company was started in 1987 and is based in California, United States. A biopharmaceutical firm founded on research, Gilead Sciences, Inc. finds, creates, and markets medications to improve the treatment of people with fatal illnesses. The company successfully acquired Tmunity Therapeutics through Kite Pharma in February 2023.

Definition:

 Sterile injectable medications are under the category of parenteral medications, a group of medications that are not used orally and are not absorbed through the digestive system. These biologics, which are sterile injectables, are composed of both tiny and large molecules.